Volume 114, Issue 1 pp. 211-218

Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic–severe combined immunodeficient assay

Karen K. Ballen

Karen K. Ballen

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
Helen Valinski

Helen Valinski

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
Dale Greiner

Dale Greiner

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
Leonard D. Shultz

Leonard D. Shultz

Jackson Laboratory, Bar Harbor, ME, USA

Search for more papers by this author
Pamela S. Becker

Pamela S. Becker

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
Chung Cheng Hsieh

Chung Cheng Hsieh

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
F. Marc Stewart

F. Marc Stewart

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
Peter J. Quesenberry

Peter J. Quesenberry

University of Massachusetts Cancer Center, Worcester, MA, and

Search for more papers by this author
First published: 12 January 2002
Citations: 25
Karen K. Ballen, MD, UMass Memorial Health Care, 55 Lake Avenue North, Worcester, MA 01655, USA. E-mail: [email protected]

Abstract

Umbilical cord blood is an alternative stem cell source for patients without matched family donors. In this study, we examined several parameters that have not been studied in detail – radiation dose, cell dose, age of mice, and maternal and neonatal characteristics of the cord blood donor – that affect engraftment of cord blood in non-obese diabetic–severe combined immunodeficient (NOD–scid) mice. Engraftment, measured using flow cytometry analyses of human CD45+ cells, was highest in 400 cGy-treated mice. Successful engraftment was demonstrated up to 6 months, with a mean engraftment of 31% (range 0–67%) of human cells in recipient bone marrow. Engraftment was skewed to B lymphocytes. The radiation dose of 350 cGy resulted in superior survival of the murine recipients compared with 400 cGy (P = 0.03). The sex of the NOD–scid recipients had a significant effect on survival (female superior to male, P = 0·01), but not on engraftment. There were high levels of variability among different cord units and among animals injected with the same cord unit. This variability may limit the clinical usefulness of the NOD–scid mice as hosts for the quantification of human stem cells.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.